Please ensure Javascript is enabled for purposes of website accessibility
Now accepting applications for SPARK™ - Albireo’s Grants in Rare Liver Disease program. Learn more.

Biliary Atresia

Biliary atresia is a rare pediatric liver disease with symptoms typically developing about two to eight weeks after birth and no approved pharmacological therapies. Damaged or absent bile ducts outside the liver result in bile and bile acids being trapped inside the liver, quickly resulting in cirrhosis, and even liver failure.

There are currently no approved pharmacological treatments for biliary atresia, which impacts an estimated 40,000 to 50,000 people worldwide.

To learn more about biliary atresia, visit the American Liver Foundation or Children’s Liver Disease Foundation.

This is not an exhaustive list of organizations. Albireo assumes no responsibility for information or statements on external websites.